Kyverna Therapeutics Total Liabilities

Kyverna Therapeutics (KYTX) currently reports a total liabilities of $61M as of March 2026. That compares with $37M in the prior-year period — up 67.7% year over year. Use the charts on this page to explore Kyverna Therapeutics's total liabilities history and peer comparisons.

Kyverna Therapeutics's total liabilities increased from $37M to $61M — a 67.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kyverna Therapeutics reported $61M in total liabilities as of March 2026. That compares with $37M in the prior-year period — up 67.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $61M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kyverna Therapeutics, and consider following KYTX for alerts when major investors trade the stock.